SBI Securities’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
Other funds holding TVRD
SBI Securities's TVRD Position: Q3 2026 in Review
SBI Securities held its Tvardi Therapeutics (TVRD) position steady in Q3 2026 at 3 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #4069.
SBI Securities first reported a position in TVRD in Q4 2024 and has held it in 8 quarters since. The position peaked at $156 in Q3 2025. 62 funds tracked by Wall St. Rank hold TVRD as of Q3 2026.
- SBI Securities held 3 shares of Tvardi Therapeutics worth $4 as of Q3 2026.
- SBI Securities left its Tvardi Therapeutics share count unchanged in Q3 2026.
- Tvardi Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #4069 holding.
- SBI Securities first reported a position in Tvardi Therapeutics in Q4 2024 and has held it in 8 quarters since.
- SBI Securities's Tvardi Therapeutics position peaked at $156 in Q3 2025.
- 62 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q3 2026.
Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.